COMPARATIVE-STUDY OF THE PATIENTS WITH LOCALLY ADVANCED STAGE-I AND STAGE-II CERVICAL-CANCER TREATED BY RADICAL SURGERY WITH AND WITHOUT PREOPERATIVE ADJUVANT CHEMOTHERAPY
Se. Namkoong et al., COMPARATIVE-STUDY OF THE PATIENTS WITH LOCALLY ADVANCED STAGE-I AND STAGE-II CERVICAL-CANCER TREATED BY RADICAL SURGERY WITH AND WITHOUT PREOPERATIVE ADJUVANT CHEMOTHERAPY, Gynecologic oncology, 59(1), 1995, pp. 136-142
Ninty-two patients with locally advanced stages IB, IIA, and IIB cervi
cal cancers, who had completed 4 years of follow-up after treatment wi
th preoperative adjuvant chemotherapy prior to radical surgery, were c
ompared with 138 patients in same disease status who were treated with
radical surgery without preoperative adjuvant chemotherapy. In the pa
tients treated with preoperative adjuvant chemotherapy (VBP scheme), t
he chemotherapeutic response was more favorable in squamous cell carci
nomas (87%) than that in adenocarcinomas (38%). The detection rate of
pelvic lymph node metastasis from the surgical specimens of radical op
eration was higher in the patients of radical surgery without preopera
tive chemotherapy (34%; 47/138) than that in the preoperative adjuvant
chemotherapeutic patients (17%; 16/92, P = 0.005). Recurrence occurre
d in 50 of 138 patients (35.5%) who were treated by radical surgery wi
thout preoperative chemotherapy and in 17 of 92 patients (18.5%) who w
ere treated with preoperative adjuvant chemotherapy followed by radica
l surgery. The difference of recurrence rate between two groups was st
atistically significant (P = 0.004). The tumor-free survival of preope
rative adjuvant chemotherapeutic patients was significantly longer tha
n those in the patients without preoperative chemotherapy (P = 0.0067)
. Tumor response to chemotherapy was a valuable prognostic factor in m
anagement of patients and preoperative adjuvant chemotherapy was benef
icial in reducing pelvic lymph node metastases, reducing recurrences,
and prolonging the survival of the patients with locally advanced cerv
ical cancers, especially in stage IIA. (C) 1995 Academic Press, Inc.